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Syzygium aqueum is widely used in folk medicine. A polyphenol-rich extract from
its leaves demonstrated a plethora of substantial pharmacological properties. The
extract showed solid antioxidant properties in vitro and protected human keratinocytes
(HaCaT cells) against UVA damage. The extract also reduced the elevated levels
of ALT, AST, total bilirubin (TB), total cholesterol (TC) and triglycerides (TG) in
rats with acute CCl4 intoxication. In addition to reducing the high MDA level, the
extract noticeably restored GSH and SOD to the normal control levels in liver tissue
homogenates and counteracted the deleterious histopathologic changes in liver after
CCl4 injection. Additionally, the extract exhibited promising anti-inflammatory activities
in vitro where it inhibited LOX, COX-1, and COX-2 with a higher COX-2 selectivity than
that of indomethacin and diclofenac and reduced the extent of lysis of erythrocytes
upon incubation with hypotonic buffer solution. S. aqueum extract also markedly
reduced leukocyte numbers with similar activities to diclofenac in rats challenged with
carrageenan. Additionally, administration of the extract abolished writhes induced by
acetic acid in mice and prolonged the response latency in hot plate test. Meanwhile,
the identified polyphenolics from the extract showed a certain affinity for the active
pockets of 5-lipoxygenase (5-LOX), cyclooxygenase-1 (COX-1) and cyclooxygenase-
2 (COX-2) explaining the observed anti-inflammatory activities. Finally, 87 secondary
metabolites (mostly phenolics) were tentatively identified in the extract based on LC-
MS/MS analyses. Syzygium aqueum displays good protection against oxidative stress,
free radicals, and could be a good candidate for treating oxidative stress related
diseases.
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INTRODUCTION
Reactive oxygen species (ROS) are natural molecules in the
body. ROS are formed by the immune system and through
mitochondrial oxidative metabolism (aerobic respiration).
Environmental stress through drugs, bacterial invasion, heat,
heavy metal ions, and exposure to radiation and UV can strongly
enhance ROS production (Finkel and Holbrook, 2000).
Reactive oxygen species and/or oxidative stress are able
to cause damage to lipids, proteins, and DNA. At the DNA
level, ROS can cause mutations of genes that can lead
to malfunction of enzymes or regulatory proteins. Thus,
ROS can be involved in the pathophysiology of several
disorders, including cardiovascular diseases, hypertension,
inflammation, cancer and neurodegenerative diseases such as
Alzheimer’s and Parkinson’s disease (van Wyk and Wink, 2015,
2017).
Elevated levels of ROS are involved in a number of
physiological processes within the human body. Further to
wound debridement, they also act as a fundamental host defense
compounds and mediators of intracellular signaling cascade.
ROS levels in the body are controlled by antioxidative molecules
(glutathione) or enzymes (SOD, catalase). A functional interplay
between ROS and antioxidants is essential in maintaining cell
functions. However, ROS levels can be regulated by the uptake
of exogenous antioxidants, among them natural antioxidant
secondary metabolites, such as polyphenols, flavonoids,
carotenoids, ascorbic acid, or allicin (van Wyk and Wink, 2015,
2017).
Several species belonging to the genus Syzygium have been
extensively studied for their phytoconstituents as well as their
biological activities; among them, S. cumini, S. samarangense,
and S. jambos. The reported pharmacological activities include
antioxidant, antiviral, anti-diabetic and hepatoprotective
properties (Sobeh et al., 2018a,b).
The Water rose apple, Syzygium aqueum, a member of family
Myrtaceae, is native to Indonesia and Malaysia but is presently
widely distributed in the tropics. Several biologically active
compounds have been isolated from the plant, among them,
epigallocatechin, epigallocatechin gallate, vescalagin, castalagin,
and samarangenins A and B (Nonaka et al., 1992). Several
plant parts have been used in folk medicine. Substantial anti-
hyperglycaemic activities were reported from the leaf extract
and its individual components myricitrin, myrilgalone G and B,
phloretin and europetin 3-O-rhamnoside from plants grown in
Malaysia (Manaharan et al., 2012).
In this study, we investigated a methanol extract from
S. aqueum leaves for its antioxidant activities in vitro and in
keratinocytes (HaCaT cells). Also, the hepatoprotective activities
were studied in a rat model against CCl4-intoxicaton; in
addition, the anti-inflammatory and antinociceptive activities
were analyzed in rat and mouse models. Finally, the active
secondary metabolites were characterized using HR-UPLC-
MS/MS.
FIGURE 1 | HR-LC-MS/MS chromatogram of a methanol extract from S. aqueum leaves.
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TABLE 1 | Secondary metabolites from a methanol extract of S. aqueum leaves by HR-LC-MS/MS.
No. tR(min) [M-H]− MS/MS fragment Tentatively identified compounds
1 1.63 191 127 Quinic acida
2 2.23 341 179 Caffeoyl hexoside
3 2.87 343 191 Galloylquinic acida
4 3.02 331 169 Galloyl hexosea
5 3.26 609 305, 423, 441, 591 (epi)-Gallocatechin-(epi)-gallocatechin
6 3.88 483 169, 331 Digalloyl hexose
7 4.43 933 301, 301, 631, 915 Castalagin/Vescalagin∗,a
8 6.13 477 169, 313, 331 Gallic acid coumaroyl-hexose
9 6.28 633 301, 463, 615 Galloyl-hexahydroxydiphenoyl (HHDP)-hexoside
10 6.36 609 305, 423, 441 (epi)-Gallocatechin-(epi)-gallocatechina
11 6.51 343 125, 169 Galloylquinic acid
12 6.76 1583 765, 935, 1537, 1565 Eugeniflorin D2a
13 7.85 305 125, 179 (epi)-Gallocatechin∗,a
14 9.14 179 161 Caffeic acid
15 9.27 315 153 p-Coumaric acid hexoside
16 10.29 441 179, 271, 423 (epi)-Catechin gallate
17 12.23 301 229, 257, 301 Ellagic acidb
18 12.87 593 289, 425, 557 (epi)-Catechin-(epi)-gallocatechin
19 16.12 761 305, 423, 593, 609 (epi)-Gallocatechin-(epi)-gallocatechin gallatea
20 17.11 897 305, 559, 609, 771 (epi)-Gallocatechin-(epi)-gallocatechin-(epi)-catechin
21 17.81 783 301, 615, 765 Pedunculagin∗
22 18.21 273 187, 229 (epi)-Afzelechin
23 19.90 633 301, 481, 615 Galloyl-hexahydroxydiphenoyl (HHDP)-hexoside
24 21.20 745 289, 577, 593, 727 (epi)-Catechin-(epi)-gallocatechin gallatea
25 22.61 285 153 p-Coumaric acid pentoside
26 22.72 483 169, 331 Digalloyl hexose
27 23.41 759 229, 301, 633 Samarangenin A∗
28 24.79 577 289, 407, 425, 559 (epi)-Catechin-(epi)-catechina
29 25.74 745 305, 423, 457, 593 (epi)-Gallocatechin-(epi)-catechin gallatea
30 25.94 575 287, 423 (epi)-Catechin-A-(epi)-catechin
31 28.25 761 305, 423, 609 (epi)-Gallocatechin-(epi)-gallocatechin gallate
32 28.91 785 301, 483, 633, 765 Digalloyl- HHDP-hexoside
33 29.89 457 305, 331 (epi)-Gallocatechin gallate∗,a,U
34 33.48 745 289, 441, 593, 619 (epi)-Gallocatechin-(epi)-catechin gallatea
35 33.7 1217 423, 761, 1047, 1065 (epi)-Gallocatechin-(epi)-gallocatechin-(epi)-gallocatechin-(epi)-gallocatechina
36 34.92 1049 423, 745, 761 (epi)-Catechin-(epi)-gallocatechin -(epi)-gallocatechin gallatea
37 35.94 785 301, 483, 615, 633, 765 Digalloyl-HHDP-hexoside
38 37.00 1201 423, 475, 1049 (epi)-Catechin-(epi)-gallocatechin-(epi)-gallocatechin-(epi)-gallocatechin
39 37.27 367 191 Feruloylquinic acid
40 37.5 337 191 p-Coumaroylquinic acida
41 38.82 881 423, 591, 729 (epi)-catechin gallate-(epi)-catechin gallate
42 40.71 1217 423, 761, 913, 1030 (epi)-Gallocatechin-(epi)-gallocatechin-(epi)-gallocatechin-(epi)-gallocatechina
43 41.09 441 169, 289 (epi)-Catechin gallate∗,a
44 42.18 1017 407, 575, 729 (epi)-Catechin-(epi)-catechin-(epi)-catechin gallatea
45 42.23 913 423, 591, 761 Prodelphinidin B2 3,3′-digallate∗
46 43.13 451 169, 289 (epi)catechin glycoside
47 45.41 911 285, 423, 571, 759 Samarangenin B∗
48 49.03 625 317, 463 Myricetin rhamnosyl-hexosidea
49 49.53 479 317 Myricetin hexosidea
50 50.27 449 179, 317 Myricetin pentosidea
51 51.72 595 179, 271, 301, 463 Quercetin pentosyl-hexoside
52 52.08 623 285, 447 Myrigalone-G glucuronide-hexoside
(Continued)
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TABLE 1 | Continued
No. tR(min) [M-H]− MS/MS fragment Tentatively identified compounds
53 53.15 463 179, 317 Myricetin3-O- rhamnoside∗,a,U
54 54.43 375 361 Methyligstroside aglycone
55 54.83 631 317, 479 Myricetin galloly-hexoside
56 56.85 729 289, 407, 559 Procyanidin dimer monogallatea
57 57.15 593 285, 447 Myrigalone-G rhamnosyl-hexoside
58 57.22 601 317, 449 Myricetin galloyl-pentoside
59 57.9 881 289, 407, 559, 729 (epi)-Catechin gallate-(epi)-catechin gallatea
60 58.08 493 331 Europetin hexoside
61 58.18 609 301 Quercetin rutinosidea
62 58.33 645 331, 493 Europetin galloly-hexoside
63 58.51 737 300, 433 Quercetin pentosyl digallate
64 58.58 749 301, 447, 595, 597 Quercetin rhamnosyl-digallate
65 62.17 433 301 Quercetin pentoside
66 63.36 477 331 Europetin rhamnoside∗
67 63.84 447 301 Quercetin rhamnoside
68 64.04 615 317, 463 Myricetin galloyl-rhamnosidea,c
69 64.13 615 301, 463 Quercetin galloyl-hexosidea
70 64.8 447 315 Isorhamnetin pentoside
71 64.98 417 285 Myrigalone-G pentoside
72 65.28 461 315 Isorhamnetin rhamnoside
73 65.3 585 301, 433 Quercetin galloyl-pentosidea
74 66.34 601 179, 317, 449 Myricetin galloyl-pentoside
75 66.43 935 301, 463, 633, 783 Quercetin hexoside trigallate
76 67.01 599 301, 447 Quercetin galloyl-rhamnoside
77 67.36 615 317, 463 Myricetin galloyl-rhamnosidea
78 68.06 417 285 Myrigalone-G pentoside
79 68.15 523 361 Ligstroside
80 68.26 431 285 Myrigalone-G rhamnoside
81 68.27 329 285 Acetylemyrigalone-G∗
82 69.09 461 329 Tricin pentoside
83 69.35 585 179, 301, 433 Quercetin galloly-pentoside
84 71.56 629 179, 301, 463, 477 Quercetin methyl galloyl-hexoside
85 72.11 299 151, 243, 271 Myrigalone-B∗
86 73.36 285 163, 241, 271 Myrigalone-G∗
87 74.20 269 121, 255, 271 Cryptostrobina
∗Previously isolated from the plant (Nonaka et al., 1992) and (Manaharan et al., 2012). U Identification was confirmed using authentic standard compounds. a Identification
was based on Sobeh et al. (2018b). b Identification was based on Sobeh et al. (2018a).
MATERIALS AND METHODS
Plant Material and Extraction
The leaves of S. aqueum were collected from trees grown
in private garden, Egypt. The species was identified by
Mrs. Therese Labib, Consultant of Plant Taxonomy at the
Ministry of Agriculture and El-Orman Botanical Garden, Giza,
Egypt. A voucher specimen (accession number: PHG-P-SA-
181) was deposited at Pharmacognosy Department, Faculty of
Pharmacy, Ain Shams University. The air-dried and milled leaf
powder (100 g) was extracted with 100% methanol at ambient
temperature (3 × 500 mL). The whole mixture was filtered and
concentrated under vacuum at 40◦C giving a semisolid residue.
The latter was frozen at −70◦C and lyophilized for 72 h yielding
fine dried powder (12 g).
LC–HRESI-MS–MS
An HPLC Agilent 1200 series instrument was used to analyze the
sample. A Gemini 3 µm C18 110 A◦ column from Phenomenex
with dimensions 100 × 1 mm i.d., protected with RP C18
100 A◦ guard column with dimensions (5 mm × 300 µm i.d.,
5 µm) was used. The mobile phase was (A) 2% acetic acid and
(B) 90% MeOH, 2% acetic acid at a flow rate of 50 µL/min.
The gradient was from 5% B at 0 min to 50% B in 50 min
and then increased to 90% in 10 min and kept for 5 min.
Fourier transform ion cyclotron resonance mass analyzer was
used equipped with an electrospray ionization (ESI) system. The
system was controlled using X-calibur R© software. The data were
collected in the negative ion mode as described before (Sobeh
et al., 2018b). The full mass scan covered the mass range from
150 to 2000 m/z with resolution up to 100000.
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TABLE 2 | Antioxidant properties of the extract as compared to positive controls EGCG and vitamin C.
Assay S. aqueum extract EGCG Ascorbic acid
DPPH (EC50 µg/mL) 6.80 ± 0.15 3.50 ± 0.23 2.95 ± 0.13
TEAC (Trolox equivalents/mg of sample) 2073 ± 17 5293 ± 23 −
FRAP (Fe2+ equivalents/mg of sample) 11.51 ± 0.82 25.23 ± 1.32 −
TAC (Total antioxidant capacity, U/L) 18.72 ± 1.11 26.41 ± 1.75
FIGURE 2 | Effect of Syzygium aqueum extracts on human keratinocytes. (A) Biocompatibility of S. aqueum extract in dose (25–200 µg/mL) and time (24–48 h)
manner. Survival rate of the cells was assessed by the MTT assay. (B) ROS production in cells treated or untreated with theextract (100 µg/mL) and then irradiated
by 100 J/cm2 UVA (+) or not (–). (C) Total GSH levels determined by DTNB assay. Results expressed as mean ± SD of three assays. Significant ∗p < 0.01;
∗∗p < 0.001 compared to untreated control. Analysis performed by two-way ANOVA followed by Bonferroni’s multiple comparisons test. (D) Immunoblotting bands
of the oxidative stress activated protein, p38. An equal amount (100 µg) of total lysate from each sample was resolved by SDS-PAGE with GAPDH as a control.
Biological Activity
Antioxidant Activities in Vitro
Total phenolic contents were determined using the Folin-
Ciocalteu method and the antioxidant activities were investigated
by DPPH radical scavenging activity, FRAP assay and ABTS
assay, as previously described (Ghareeb et al., 2017).
Total Antioxidant Capacity (TAC) Assay
Total antioxidant capacity was assessed using a commercially
available TAC ELISA kit (MBS726896, MyBioSource, Inc., San
Diego, CA, United States) according to the manufacturer’s
instructions using ascorbic acid as the reference standard. Briefly,
the extract, ascorbic acid or PBS were incubated with TAC-
HRP conjugate in pre-coated plate for 1 h. This was followed by
proper washing and incubation with a substrate for HRP enzyme.
A yellow color was formed which is inversely proportional to the
TAC concentration. After 30 min, the stop solution was added to
terminate the reaction. The intensity of the yellow color formed
was measured at 450 nm in a microplate reader (Molecular
Devices, Sunnyvale, CA, United States). A standard curve was
established using serial dilutions of the standard. The sample
activity (U/L) was calculated from the standard curve equation.
Cell Culture and MTT Assay
Human epidermal keratinocytes (HaCaT), provided by Innoprot
(Biscay, Spain), were cultured as described in Petruk et al. (2016).
For dose and time dependent biocompatibility experiments, cells
were seeded in 96-well plates at a density of 2 × 103cells/well.
Twenty four hour after seeding, increasing concentrations of the
methanol extract (from 25 to 200 µg/mL) were added to the cells
for 24 and 48 h. Cell viability was assessed by the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay as
described in Monti et al. (2015). Cell survival was expressed
as the percentage of viable cells in the presence of the extract
compared to controls. Two groups of cells were used as control,
i.e., untreated cells and cells supplemented with identical volumes
of buffer. Each sample was tested in three independent analyses,
each carried out in triplicates.
Oxidative Stress in HaCaT Cells
To investigate oxidative stress, HaCaT cells were plated at a
density of 2× 104 cells/cm2. Twenty four hour after seeding, cells
were incubated for 2 h in the presence or absence of 100 µg/mL
of the extract and then exposed to UVA (100 J/cm2). Then, ROS
levels, intracellular GSH levels and the phosphorylation of p38
were analyzed as described in Petruk et al. (2016). The other
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FIGURE 3 | Hepatoprotection through a methanol extract of S. aqueum leaves in a rat model of acute CCl4 intoxication. (A) Alanine aminotransferase (ALT) activity;
(B) Aspartate aminotransferase (AST); (C) Total bilirubin (TB); (D) Total cholesterol (TC); (E) Triglycerides (TG). Results are shown as means ± SD, n = 6, by one-way
ANOVA followed by Tukey post hoc test. aStatistically significant from the corresponding control at p < 0.05, bStatistically significant from CCl4-treated group at
p < 0.05.
assays namely DCFDA assay, DTNB assay and Western blot
analyses were performed as described in Petruk et al. (2016).
Hepatoprotective Activity in Vivo
Animals and experimental design
Male Sprague-Dawley rats, weighing 200–250 g, were purchased
from the animal resource branch, King Abdulaziz University,
Geddah (KSA). The rats were fed on rodent chow and water
ad libitum and housed in conventional cages at 22 ± 2◦C, with
a 12 h light–dark cycle. The study protocol was approved by
the Unit of Biomedical Ethics Research Committee, Faculty of
Medicine, King Abdulaziz University, following the Institutional
Animal Care and Use Committee guidelines (Reference # 157-
14). In brief, 24 rats were divided into four groups. Group
(1) served as a control and obtained water orally followed by
intraperitoneal (i.p.) injection of corn oil after 4 h. Group (2)
was injected a single dose of CCl4-corn oil (Sigma–Aldrich, St.
Louis, MO, United States) (1 ml/kg, of 50% mixture). Group (3)
served as a positive control and was administered the known
hepatoprotective silymarin (200 mg/kg orally). Group (4) was
pretreated with S. aqueum extract (200 mg/kg orally). Groups (3
and 4) were injected CCl4-corn oil (1 ml/kg, of 50% mixture, i.p.)
after 4 h from the pretreatment (Sobeh et al., 2018a).
Twenty four hour after the treatments, the rats were
anesthetized, and blood samples were collected by cardiac
puncture, allowed to clot, centrifuged for 10 min at 2113 × g,
and then kept at −80◦C until analysis. Finally, the rats were
sacrificed, and liver tissues were dissected. The liver tissues were
cut and fixed in 10% formalin/saline and embedded in paraffin for
histopathological investigations. The remaining liver tissues were
re-weighed, washed and homogenized in ice-cold PBS to yield
10% w/v homogenates and then stored at−80◦C until analyses.
Frontiers in Pharmacology | www.frontiersin.org 6 June 2018 | Volume 9 | Article 566
fphar-09-00566 June 1, 2018 Time: 13:27 # 7
Sobeh et al. Syzygium aqueum Counteracts Oxidative Stress
FIGURE 4 | Influence of a methanol extract of S. aqueum leaves on antioxidative enzyme activities in rats with acute CCl4 intoxication. (A) Liver glutathione (GSH);
(B) Lipid peroxidation and generation of malondialdehyde (MDA); (C) Superoxide dismutase (SOD). Results are shown as means ± SD, n = 6, by one-way ANOVA
followed by Tukey post hoc test. aStatistically significant from the corresponding control at p < 0.05, bStatistically significant from CCl4-treated group at p < 0.05.
Liver biomarkers
Mindray BS-120 clinical chemistry auto-analyzer (Shenzhen
Mindray Bio-Medical Electronics Co. Ltd., Shenzhen, China)
was used to determine the activities of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), total bilirubin (TB),
total cholesterol (TC), and triglycerides (TG). The levels of
oxidative stress markers glutathione (GSH), lipid peroxidation
marker malondialdehyde (MDA) and the activity of the
antioxidant enzyme superoxide dismutase (SOD) were quantified
utilizing the commercially available kits (Biodiagnostics, Cairo,
Egypt).
Histopathological examination
Liver tissue samples were stored in 10% buffered neutral formalin
for 24 h and then washed with tap water. Dehydration was
conducted using serial dilutions of methyl, ethyl and absolute
ethyl alcohols. The tissue sections were then embedded in xylene,
immersed in paraffin, and dried inside hot air oven at 56◦C
for 24 h. Tissue sections, 4 µm thickness, were prepared using
slide microtome, placed on glass slides, and stained with eosin
and hematoxylin. The latter was investigated using the light
electric microscope (Olympus BX-50 Olympus Corporation,
Tokyo, Japan) as described in Sobeh et al. (2018a).
Anti-inflammatory Activities
In Vitro Anti-inflammatory activities
The capacity of the extract to inhibit lipoxygenase was
determined using a lipoxygenase inhibitor screening assay kit
(Cayman Chemical, Ann Arbor, MI, United States) according
to the manufacturer’s instruction and reported study (Abdelall
et al., 2016). The ability of the extract to inhibit ovine COX-1
and COX-2 was determined by using an enzyme immunoassay
(EIA) kit (Cayman Chemical, Ann Arbor, MI, United States)
according to the manufacturer’s instruction and reported studies
(Abdelall et al., 2016). The data are expressed as IC50 value,
which is the concentration causing 50% enzyme inhibition (IC50).
Furthermore, the COX-2 selectivity index (SI values) which
is defined as IC50 (COX-1)/IC50 (COX-2) was calculated and
compared to that of celecoxib, indomethacin, and diclofenac
which were used as reference standards.
Membrane stabilizing activity (hypotonic solution-induced
hemolysis)
The membrane stabilizing activity of the extract was assessed in
erythrocytes; hemolysis was induced by osmotic shock (Shinde
et al., 1999). Fresh whole blood (10 mL) was collected from
a healthy human volunteer who had not taken any NSAIDS
for 2 weeks prior to the experiment. This was followed by
centrifugation of heparinized blood (2113 × g/10 min) and
washing with normal saline. Next, a 40% (v/v) RBCs suspension
in 10 mM sodium phosphate buffer solution (NaH2PO4. 2H2O,
0.26 g; Na2HPO4, 1.15 g; NaCl, 9 g) was prepared. A 0.5 mL
of the previous suspension was incubated for 10 min with
5 mL of hypotonic solution (50 mM NaCl in 10 mM sodium
phosphate buffered saline, pH 7.4) containing with the extract
(1000 µg/mL), aspirin or diclofenac (100 µg/mL) as reference
drugs. The samples were then centrifuged at 3000 g for10 min.
The absorbance of the supernatant was then detected at 540 nm.
The ability of the tested sample to inhibit RBCs hemolysis was
calculated using the following equation:
Hemolysis inhibition % = (OD1−OD2/OD1) × 100
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FIGURE 5 | Hepatoprotective potential of S. aqueum leaf extract on liver
pathology after CCl4 treatment in rats, stained by hematoxylin-eosin. (A) Liver
of normal control rat with normal hepatic architecture, hepatocyte structure
and central vein. (B) Liver afterCCl4 intoxication with severe changes including
dilated central vein with central hepatocellular necrosis (arrows) and
congested portal triad. (C) Liver of a rat treated with silymarin prior to
CCl4administration; only scattered cytoplasmic vacuolization (arrows) were
detected. (D) Liver of a rat treated with the extract (200 mg/kg, b.w.) prior to
CCl4 injection showing scattered cytoplasmic vacuolization (arrows).
where OD1=Optical Density of the control (cells incubated with
the buffer only) and OD2= Optical Density of test sample.
Carrageenan-induced hind-paw edema
Right hind paw edema was induced in rats by injecting freshly
prepared carrageenan solution (1% in 0.9% NaCl, 0.1 mL),
into the sub plantar tissue. 1 h earlier, the vehicle (10 mL/kg),
S. aqueum extract (300 mg/kg, p.o.) or diclofenac (10 mg/kg)
were given orally. The paw thickness (mm) was measured in
the dorsal- plantar axis by a caliper ruler before and after the
carrageenan injection at hourly intervals for 6 h and then at
24 h. The cumulative anti-inflammatory effect during the whole
observation period (0–24 h) was estimated by calculating the area
under changes in paw thickness-time curve (AUC0−24).
TABLE 3 | Inhibition activities of the extract on LOX, COX-1, and COX-2 enzymes.
IC50 (µg/mL) IC50 (µg/mL)
Treatment LOX COX-1 COX-2 SI
S. aqueum extract 2.54 ± 0.19 7.11 ± 0.43 0.12 ± 0.005 59.3
Celecoxib − 15.1 ± 0.72 0.049 ± 0.002 308.2
Diclofenac 2.11 ± 0.14 3.8 ± 0.17 0.84 ± 0.04 4.5
Indomethacin − 0.041 ± 0.001 0.51 ± 0.02 0.08
Zileuton 3.51 ± 0.21 − − −
SI is COX selectivity index which is defined as IC50 (COX-1)/IC50 (COX-2).
Recruitment of leukocyte to peritoneal cavity in mice
The recruitment of leukocytes to the peritoneal cavity was
assessed as described previously (Silva-Comar et al., 2014).
Briefly, Swiss albino mice (n = 5–8/group), were orally
treated with the vehicle (1 mL/100 g, p.o.) or S. aqueum
extract (300 mg/kg) 30 min before the intraperitoneal
injection of 0.1 mL carrageenan solution (500 µg/mice) or
0.1 mL sterile saline. Diclofenac (10 mg/kg, p.o.) was used
as the reference anti-inflammatory drug. The animals were
euthanized 3 h later and the peritoneal cavity was washed with
3 mL of phosphate-buffered saline (PBS) contained 1 mM
ethylenediaminetetraacetic acid (EDTA). The total leukocyte
count was determined in the peritoneal cavity wash using a
hemocytometer and expressed as number of cells/mL.
Antinociceptive Activity
Acetic acid-induced abdominal writhing
The peripheral analgesic activity of the extract was evaluated
using acetic acid induced writhing model in mice (Nakamura
et al., 1986). The animals were divided into three groups (5–7
mice). Group (1) received the vehicle (1% Tween 80, 10 mL/kg)
and served as negative control. Group (2) received the extract
(300 mg/kg, p.o.) and group (3) received diclofenac (10 mg/kg,
a reference drug) 1 h prior i.p. injection of 0.7% acetic acid
(1 mL/100g). The number of writhes (constriction of abdomen,
turning of trunk and extension of hind legs) was observed for
25 min.
Hot plate test
The hot plate test was carried out to test a possible central
analgesic activity of the extract (Macdonald et al., 1946; Eddy
and Leimbach, 1953). Mice were divided in different groups (5
each) and receive either the extract (300 mg/kg, p.o.) or the
vehicle (10 mL/kg, p.o.). Another group of mice received the
opioid analgesic nalbuphine as reference central analgesic. After
60 min, the mice were individually placed in a hot plate heated at
55 ± 1◦C and the animal was studied for any sign of response to
heat-induced nociceptive pain (licking of the fore and hind paws,
hind paw lifting or jumping). The latency until mice showed the
first signs of discomfort was recorded before (baseline) and at 1,
2, 3, and 4 h following different treatments.
Molecular Modeling
In silico virtual screening studies of the major constituents
identified in the bioactive methanol extract of S. aqueum was
performed using the C-docker protocol on 5-lipoxygenase (PDB
ID 3V99, 2.48 Å), cyclooxygenase-I (PDB ID 2OYE, 2.85 Å) and
TABLE 4 | Effects of the extract, aspirin, and diclofenac on hemolysis of human
erythrocyte membranes caused by hypotonic buffer.
Treatment Concentration (µg/mL) Hemolysis inhibition (%)
S. aqueum extract 1000 35.84 ± 0.93
Aspirin 100 68.32 ± 0.73
Diclofenac 100 81.63 ± 1.2
Data is presented as mean ± SEM of three different experiments.
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FIGURE 6 | Anti-inflammatory activities of S. aqueum leaf extract. (A) Effect of 1 h prior administration of S. aqueum (300 mg/kg, p.o.) or diclofenac (10 mg/kg, p.o.)
on carrageenan (1% suspension, 0.1 ml/rat) induced-hind paw edema in rats. Edema thickness (mm) was measured before and then hourly for 6 h and at 24 h after
carrageenan injection. Data represents the AUC0-24 and are expressed as mean ± SEM (n = 5–7). (B) Effect of carrageenan (500 µg, i.p.) on leukocytes migration
into the peritoneal cavity (total number × 106) with or without 1 h prior treatment with the extract (300 mg/kg, p.o.) or diclofenac (10 mg/kg, p.o.). Data are
expressed as mean. ± SEM (n = 5–7). ∗p < 0.01 vs. control values; #p < 0.05 vs. carrageenan.
FIGURE 7 | Antinociceptive activities of S. aqueum leaf extract. (A) Effect of S. aqueum extract (300 mg/kg, p.o.) or diclofenac (10 mg/kg, p.o.) on acetic
acid-induced writhing (0.7%, 1 mL/100 g) in mice. (B) Hot plate response latency measured 1–4 h after vehicle, extract (300 mg/kg, p.o.) or nalbuphine (10 mg/kg,
p.o.) administration in mice. Data is expressed as mean ± SEM (n = 5–7). ∗p < 0.001 vs. control values.
cyclooxygenase-II (PDB ID 3LN1, 2.3 Å) that were downloaded
from protein data bank1. This was done by applying both
pH and rule-based ionization methods for the preparation of
ligands with Discovery Studio 2.5 (Accelrys Inc., San Diego, CA,
United States). In silico virtual screening was performed within
the active pocket of the previously mentioned enzymes and the
free binding energies for the highly stable docking poses were
calculated as previously discussed (Sobeh et al., 2016; Ashour
et al., 2017; Youssef et al., 2017).
Data Analysis
Data were analyzed using GraphPad Prism software, version 5.00
(GraphPad Software, Inc., La Jolla, CA, United States). Analysis
1www.pdb.org
of Variance (ANOVA) or repeated-measures analysis of variance
(RM-ANOVA) followed by Tukey’s post hoc test and Student’s
t-test were used to state differences between groups. Otherwise
mentioned, data are expressed as mean± SEM.
RESULTS
Secondary Metabolites From S. aqueum
Utilizing high resolution LC-ESI-MS/MS, 87 compounds
were characterized in a methanol extract of S. aqueum
leaves. Flavonoids, represented by myricetin rhamnoside
(53), myrigalone-G pentoside (71), quercetin galloyl-pentoside
(73), cryptostrobin (87), myrigalone-B (85), and myrigalone-G
(86) dominated the extract, in addition, proanthocyanindins with
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mainly samarangenin A (27), (epi)-gallocatechin gallate (33),
and (epi)-catechin-(epi)-gallocatechin-(epi)-gallocatechin gallate
(36) were abundant. Also, digalloyl-hexahydroxydiphenoyl
(HHDP)-hexoside (37), as an example for ellagitannins,
was among the major constituents. Some phenolic acid
derivatives and other ellagitannins were characterized as well
(Figure 1 and Table 1). Representative MS/MS fragmentation
of some identified compounds are presented in Supplementary
Figures S1–S45.
Antioxidant Activities in Vitro and in
Keratinocytes
Initially, we evaluated the antioxidant potential of the leaf
extract in vitro using DPPH·, TEAC and FRAP assays as well
as total antioxidant capacity (TAC), as reported in Table 2.
The total phenolic content amounted to 453 mg GAE/g extract.
The extract demonstrated substantial activities in all assays.
(epi)Gallocatechin gallate (EGCG) and ascorbic acid were used
as reference compounds.
We also investigated the antioxidant capacity of the extract
in human keratinocytes. First, we tested the biocompatibility of
the extract in HaCaT cells by a time-course and dose-response
test, using increasing amount of extract (from 25 to 200 µg/mL).
As shown in Figure 2A, cell viability was not significantly
affected at any of the concentration and time analyzed. Then, we
investigated whether the extract had protective properties against
oxidative stress. In all the experiments, cells were pre-treated with
the extract (100 µg/mL) for 2 h before challenging cells with
UVA irradiation to induce oxidative stress (100 J/cm2). At the
end of the incubation, intracellular ROS levels were analyzed by
using H2DCF-DA (2,7-dichlorofluorescin diacetate) (Figure 2B).
It is apparent that UVA significantly increased DCF fluorescence
intensity, compared to the non-irradiated cells. However, pre-
treatment of the cells with the extract showed reduced ROS
levels. The UVA induced increase in ROS levels is normally
followed by a decrease in total GSH levels. In fact, as shown in
Figure 2C, cells irradiated by UVA have dramatically reduced
GSH levels. As expected, cells pre-treated with the extract and
then exposed to oxidative stress showed unaltered GSH levels,
compared to the untreated cells. The ability of the extract to
protect HaCaT cells from UVA damages was confirmed by
Western blot analysis. In particular, a mitogen activated protein
kinase (p38) phosphorylation levels were analyzed (Figure 2D).
We found that treatment of cells with extract does not activate
this protein. Instead, as expected, UVA induced a significant
increase in the phosphorylation levels of p38. On the other
hand, when cells were pre-incubated with the extract and then
exposed to UVA radiations, the phosphorylation levels of p38
were significantly lower to that observed in irradiated cells.
Hepatoprotective Activities
In order to validate the in vitro and cell culture results, we
tested the antioxidant activity of the extract in vivo. Thus,
the preventive action of the extract against the intoxication of
CCl4 in rats was determined. CCl4 administration elevated all
markers for liver damage. When the rats were treated with the
extract prior CCl4 injection, protective activities were observed
in all liver parameters. The extract (200 mg/kg b.w.) significantly
reduced the elevated levels of ALT, AST, TB, TC, and TG,
comparable to activities of the standard lignin from Silybum
marianum, silymarin, Figure 3. Also, CCl4 injection significantly
decreased the levels of GSH and SOD and increased MDA level
in liver tissue homogenates. The extract markedly restored their
levels to the normal control levels except for MDA, Figure 4.
The hepatoprotection through the leaf extract was then further
evidenced using a histopathologic study. The extract protected
the liver against the deleterious effect of CCl4, Figure 5.
Anti-inflammatory Activities
Besides the antioxidant and hepatoprotective activity of
theextract, we investigated its anti-inflammatory activity.
In particular, we examined the ability of the extract to
inhibit lipoxygenase (LOX) and cyclooxygenases (COX1/2).
Interestingly, the extract inhibited LOX stronger than zileuton,
the reference LOX inhibitor, as reported in Table 3. Additionally,
the extract was able to inhibit both COX-1 and COX-2
TABLE 5 | Free binding energies (kcal/mol) of the identified compounds in 5-LOX, COX-1 and COX-2 active sites using molecular modeling experiments.
Compound 5-LOX COX-1 COX-2
Rule- based
ionization
pH –based
ionization
Rule- based
ionization
pH –based
ionization
Rule- based
ionization
pH –based
ionization
NDGA (lead) −44.49 −65.44 NT NT NT NT
Diclofenac (lead) −30.07 −34.64 −40.06 −40.72 −40.14 −40.74
epiGallocatechin gallate −61.15 −56.22 −64.67 −66.33 −61.24 −67.13
Cryptostrobin −31.58 −45.63 −40.80 −44.04 −39.60 −47.04
Europetin rhamnoside −54.14 −58.23 −61.41 −63.90 −56.53 −66.52
Myricetin rhamnoside −50.44 −61.19 −61.75 −57.07 −57.16 −67.74
Myrigalone B −30.89 −31.62 −37.01 −37.83 −37.03 −41.87
Myrigalone G −38.15 38.31 −43.49 −47.63 −49.87 −49.97
Samarangenin A FD 58.70 FD FD FD FD
Epicatechin-epigallocatechin-epigallocatechin gallate −123.93 −123.62 FD FD FD FD
NT, not tested. FD, fail to dock.
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FIGURE 8 | 2D and 3D binding mode of (A) epicatechin-epigallocatechin-epigallocatechin gallate in 5-LOX, (B) epigallocatechin gallate in COX-1, (C) myricetin
rhamnoside in COX-2 active sites using molecular modeling experiments applying pH-based ionization method.
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FIGURE 9 | (A) Active pockets showing epicatechin-epigallocatechin-epigallocatechin gallate in 5-LOX, (B) (epi)-gallocatechin gallate in COX-1, (C) myricetin
rhamnoside in COX-2.
in vitro. Moreover, the extract exhibited a SI value of 59.3,
indicating higher selectivity toward COX-2 compared to COX-1.
Noteworthy, the extract showed a higher COX-2 selectivity than
that of indomethacin and diclofenac, but lower than that of
celecoxib, as reported in Table 3.
In another experiment, we studied if the extract could
counteract membrane disturbance in red blood cells (RBCs).
At 1 mg/mL, the extract reduced the extent of RBCs lysis
upon incubation with hypotonic buffer solution. Aspirin and
diclofenac were used as reference drugs (Table 4).
We also explored the in vivo anti-inflammatory properties
of the extract using the well characterized model, carrageenan-
induced paw edema (Winter et al., 1962; Zhang et al., 2008).
Rats pre-treated with the extract (300 mg/kg, p.o.) 1 h before
sub-planter carrageenan injection (1% suspension, 0.1 mL/rat)
significantly attenuated carrageenan-induced paw edema and
decreased the AUC0−24 value by14.15 %. The positive control,
diclofenac, decreased AUC0−24 value by 38.2%, as reported in
Figure 6. The control group was set to 100%.
Carrageenan (500 µg/cavity, i.p., 0.1 mL) induced a
significant leukocyte migration in the peritoneal cavity of
mice (7.6 ± 1.2 × 106 leukocytes/mL). Animals were pretreated
with the extract (300 mg/kg, p.o.) 1 h prior carrageenan
challenge; this significantly reduced leukocyte numbers by 50%
when compared to vehicle-treated mice, (p < 0.05), as reported
in Figure 6B. Similar activities were observed by a standard
anti-inflammatory compound, diclofenac (10 mg/kg, p.o.).
Antinociceptive and Analgesic Activities
In addition to the aforementioned activities, we researched the
antinociceptive and analgesic activities of the leaf extract in vivo
against acetic acid-induced writhing. As shown in Figure 7A,
oral pre-treatment with the extract (300 mg/kg) almost abolished
(96% reduction) the writhes induced by acetic acid in mice when
given 1 h earlier (p < 0.001) compared to control. Diclofenac, a
reference analgesic drug, achieved 65% reduction of the control
writhes, (p < 0.001). These activities were also confirmed using
hot plate test in mice where animals pre-treated with the extract
(300 mg/kg, p.o.) prolonged the response latency when measured
at 1, 2, 3, and 4 h after administration. This effect was significant
at 1 and 2 h (14 ± 2.8 and 14.6 ± 2.5 s, respectively) post-
treatment when compared to the control group (3.8 ± 0.5
and 4.2 ± 0.58 s, respectively). The standard reference drug,
(nalbuphine, 10 mg/kg, i.p.), significantly increased response
latency all tested time points with the maximum effect achieved
at the 2 h (17.5± 3.37 s) (Figure 7B).
In Silico Virtual Screening
In silico virtual screening studies were carried out on three
crucial enzymes implicated in the occurrence and subsequent
progression of inflammation namely, 5-lipoxygenase (5-LOX),
cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Most
of the docked compounds showed certain stability within the
active pockets of all tested enzymes except for samarangenin
A and epicatechin-epigallocatechin-epigallocatechin gallate that
failed to dock in both COX-1 and COX-2 owing to the relatively
larger size of the molecules comparable to the active pockets of
target enzymes (Table 5).
Among all the docked compounds, epicatechin-
epigallocatechin-epigallocatechin gallate revealed the greatest
stability with a pronounced highest fitting in the active
site of 5-LOX displaying free binding energies of −123.62
and −123.93 kcal/mol, in the pH-based and rule-based
ionization methods, respectively. In this virtue, it highly
exceeds that of nordihydroguateric acid (NDGA), the potent
well-known 5-LOX inhibitor that showed 1G of −65.44
and −44.49 kcal/mol applying both previously mentioned
methods, respectively. The apparent stability of epicatechin-
epigallocatechin-epigallocatechin gallate in the active site of
5-LOX is strongly attributed to the formation of numerous firm
hydrogen bonds with Ala 672, Asp 176, Gln557, Gln 363, Gln
609, Gly 174, Lys 173, Lys 409, Val 175, Val 671 and Thr 364
amino acid moieties in the active pocket in addition to a tight
pi-bond formation with Phe 177 as showed in the pH-based
ionization method illustrated in Figure 8.
Regarding COX-1, (epi)-gallocatechin gallate revealed the
highest fitting as manifested from the free binding energies,
which are−66.33 and−64.67 kcal/mol in the pH and rule-based
ionization methods, respectively. This firm stability in the active
pockets is mainly due to the formation of six stable hydrogen
bonds with Arg 120, Gln 192, Ile 517, Tyr 355, Trp 387 Ser 530
in addition to a pi-pi interaction and ionic bond with Arg 120
as revealed from the pH-based ionization method (Figure 8).
Meanwhile, myricetin rhamnoside showed the highest fitting
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in COX-2 displaying free binding energies of −67.74 kcal/mol,
in the pH-based ionization method with −57.16 kcal/mol in
the rule-based ionization method. The tight fitting of myricetin
rhamnoside in the active site of COX-2 could be explained in
terms of the formation of four firm hydrogen bonds with Arg 106,
Arg 499, Tyr 371 and Ser 333 amino acid residues existing at the
active site in addition to the formation of a pi-pi bond with His 75
as illustrated from the pH-based ionization method (Figure 8).
The presence of epicatechin-epigallocatechin-epigallocatechin
gallate, (epi)-gallocatechin gallate and myricetin rhamnoside
within the active pockets of 5-LOX, COX-1 and COX-2 were
illustrated in Figure 9.
However, the effect of ionization of different functional groups
as well as amino acid moieties at the active site is well interpreted
by the rule-based ionization method. This was reflected by the
formation of an extra ionic bond between the phenolic hydroxyl
groups that dissociate to form negatively charged phenolate
ions in (epi)-gallocatechin gallate and positively charged amino
groups as Arg 106 at COX-1 active site. Furthermore, an ionic
bond was also observed between Arg 106 at COX-2 active site and
the negatively charged phenolate ions in myricetin rhamnoside.
DISCUSSION
The present study profiled the phytoactive secondary metabolites
and investigated the antioxidant, hepatoprotective, anti-
inflammatory and analgesic activities of S. aqueum leaf extract
in animal models and the underlying mechanisms. Utilizing
LC-MS/MS, 87 compounds were tentatively identified, belonging
to flavonoids, ellagitannins and proanthocyanidins. Promising
antioxidant activities were obtained in all in vitro assays
and in a cell-based model against the deleterious effects of
UVA radiations. Also, the extract was able to counteract the
deleterious effects of CCl4 in rats. These results are similar
to previous findings from Syzygium samarangense, Syzygium
jambos leaves and from other Syzygium species (Sobeh et al.,
2018a,b).
We also assessed the anti-inflammatory activity of the extract
in vitro by carrageenan-induced peritonitis, a suitable model of
acute inflammation, in which vascular changes and production
of inflammatory cytokines leading to leukocyte migration. We
focused on the early increase in vascular permeability and
neutrophil infiltration into peritoneum. The extract inhibited
both cyclooxygenases, COX-1 and COX-2 with more inhibitory
potential toward COX-2. Its effect on COX-2 was more potent
than diclofenac but less than that of celecoxib. Furthermore,
the extract inhibited lipooxygenase (LOX), thus suppressed
leukotriene synthesis and inhibited RBC hemolysis.
In addition, the extract attenuated the carrageenan induced rat
hind paw edema and inhibited carrageenan induced leukocyte
migration. The effect of the extract was comparable but less
potent than diclofenac. Also, the leaf extract demonstrated anti-
inflammatory activity and produced comparable inhibition of
leukocyte migration in comparison with diclofenac.
The response to pain stimuli in the hot plate test is attributed
to the supraspinal reflex mediated by µ-opioid receptors (Le Bars
et al., 2001). The antinociceptive activity is characterized by an
increased tolerance to pain by the animal in contact with a heated
plate. In the present study, animals pre-treated with the extract
(300 mg/kg, p.o) significantly prolonged the response latency
when measured at 1 and 2 h after administration. These results
indicate that the extract also possessed central antinociceptive
activity.
Altogether, the extract possesses solid antioxidant,
hepatoprotective, anti-inflammatory, and pain-killing activities
in vivo. These effects may be attributed to its flavonoid content,
especially myricetin rhamnoside, quercetin glucosides, and
epigallocatechin gallate. Flavonoids, among them quercetin,
and tannins possess antioxidant, hepatoprotective and anti-
inflammatory effects and play an important role in alleviating
acute inflammation (Singh and Pandey, 1997). The anti-
inflammatory effect of some flavonoids may be due to the
significant inhibitory potential against many enzymes involved
in inflammation such as phosphodiesterase, phospholipase
A2, protein tyrosine kinases, and others. Furthermore, many
flavonoids inhibit the major enzymes involved in the synthesis
of prostaglandins and leukotrienes such as COX-1, COX-2 and
LOX (Manthey et al., 2001). The extract is rich in polyphenols,
which carry several reactive phenolic hydroxyl groups; they
can partly dissociate to negatively charged phenolate ions.
Polyphenols can form several hydrogen and ionic bonds with
most proteins. As a consequence proteins complexed with
polyphenols change their 3D structures and thus modulate their
bioactivities (Wink, 2015; van Wyk and Wink, 2017). As this
polyphenol-protein interaction is not specific, several proteins
are involved, which would also explain the pleiotropic activities
of our extract.
The results observed in the different in vitro and in vivo assays
showed that S. aqueum offers good protection against oxidative
stress, free radicals and oxidative stress related diseases. More
detailed pharmacological assays are required before the findings
can be translated into applications in humans.
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